Search Results - "Peruzzotti, G"

Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ by Magnoni, F., Massari, G., Santomauro, G., Bagnardi, V., Pagan, E., Peruzzotti, G., Galimberti, V., Veronesi, P., Sacchini, V. S.

“…Background Microinvasive breast cancer is an uncommon pathological entity. Owing to the rarity of this condition, its surgical axillary management and overall…”
Get full text

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects by Colleoni, M., Orlando, L., Sanna, G., Rocca, A., Maisonneuve, P., Peruzzotti, G., Ghisini, R., Sandri, M.T., Zorzino, L., Nolè, F., Viale, G., Goldhirsch, A.

“…Background: We previously demonstrated efficacy and impact on serum vascular endothelial growth factor (VEGF) for metronomic cyclophosphamide (C) and…”
Get full text

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy by Colleoni, M., Viale, G., Zahrieh, D., Bottiglieri, L., Gelber, R.D., Veronesi, P., Balduzzi, A., Torrisi, R., Luini, A., Intra, M., Dellapasqua, S., Cardillo, A., Ghisini, R., Peruzzotti, G., Goldhirsch, A.

“…To identify the role of estrogen (ER), progesterone (PgR), epidermal growth factor 1 (HER1), and HER2 receptors in predicting response to preoperative…”
Get full text

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels by COLLEONI, M, ROCCA, A, DE BRAUD, F, VIALE, G, GOLDHIRSCH, A, SANDRI, M. T, ZORZINO, L, MASCI, G, NOLE, F, PERUZZOTTI, G, ROBERTSON, C, ORLANDO, L, CINIERI, S

“…Anticancer chemotherapy is thought to be effective by means of direct cytotoxicity on tumor cells. Alternative mechanisms of efficacy have been ascribed to…”
Get full text

Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease by Colleoni, M, Rotmensz, N, Peruzzotti, G, Maisonneuve, P, Orlando, L, Ghisini, R, Viale, G, Pruneri, G, Veronesi, P, Luini, A, Intra, M, Cardillo, A, Torrisi, R, Rocca, A, Goldhirsch, A

“…Background: There is limited knowledge about prognosis, and treatment effects in young women with node-negative disease. Patients and Methods: We evaluated…”
Get full text

Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies by Colleoni, M., Rotmensz, N., Peruzzotti, G., Maisonneuve, P., Viale, G., Renne, G., Casadio, C., Veronesi, P., Intra, M., Torrisi, R., Goldhirsch, A.

“…Background: Prognosis of patients with node-negative disease and tumor size <1 cm is a matter of controversy. While data exist to clearly correlate small tumor…”
Get full text

Systemic effects of surgery : quantitative analysis of circulating basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-β) in patients with breast cancer who underwent limited or extended surgery by CURIGLIANO, G, PETIT, J. Y, MUNZONE, E, PIETRI, E, LUINI, A, GOLDHIRSCH, A, BERTOLINI, F, COLLEONI, M, PERUZZOTTI, G, DE BRAUD, F, GANDINI, S, GIRALDO, A, MARTELLA, S, ORLANDO, L

“…To assess if feature, extent and duration of surgery could influence levels of systemic proangiogenic cytokines vascular endothelial growth factor (VEGF),…”
Get full text

Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter by Mandalà, M., Curigliano, G., Bucciarelli, P., Ferretti, G., Mannucci, P. M., Colleoni, M., Ventura, A., Peruzzotti, G., Severi, G., Pelicci, P. G., Biffi, R., Orsi, F., Cinieri, S., Goldhirsch, A.

“…Background: To analyze the influence of the prothrombotic gene mutation factor V G1691A (factor V Leiden) and prothrombin G20210A on the risk of a first…”
Get full text

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors by Colleoni, M., Minchella, I., Mazzarol, G., Nolè, F., Peruzzotti, G., Rocca, A., Viale, G., Orlando, L., Ferretti, G., Curigliano, G., Veronesi, P., Intra, M., Goldhirsch, A.

“…Background We recently demonstrated that in premenopausal patients with estrogen receptors (ER)-absent tumors, early initiation of systemic chemotherapy after…”
Get full text

Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype by Orlando, L., Renne, G., Rocca, A., Curigliano, G., Colleoni, M., Severi, G., Peruzzotti, G., Cinieri, S., Viale, G., Sanna, G., Goldhirsch, A.

“…Background:: Medullary carcinoma (MC) of the breast is associated with favorable prognosis compared with other histological types, despite high nuclear grade,…”
Get full text

Prediction of response to primary chemotherapy for operable breast cancer by Colleoni, M, Orvieto, E, Nolé, F, Orlando, L, Minchella, I, Viale, G, Peruzzotti, G, Robertson, C, Noberasco, C, Galimberti, V, Sacchini, V, Veronesi, P, Zurrida, S, Orecchia, R, Goldhirsch, A

“…The use of primary systemic cytotoxics leads to a high remission rate in patients with breast cancer. Response was identified as an important variable…”
Get full text

Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery by Cardillo, A., De Cicco, C., Paganelli, G., Ghisini, R., Peruzzotti, G., Balduzzi, A., Goldhirsch, A., Rotmensz, N., Veronesi, P., Luini, A., Intra, M., Colleoni, M.

Get full text

Preoperative and perioperative chemotherapy with 5-fluorouracil as continuous infusion in operable breast cancer expressing a high proliferation fraction: cytotoxic treatment during the surgical phase by Colleoni, M., Curigliano, G., Minchella, I., Peruzzotti, G., Nolè, F., Mazzarol, G., Renne, G., Orlando, L., Rocca, A., Veronesi, P., Intra, M., Viale, G., Sandri, M. T., Severi, G., Goldhirsch, A.

“…Background: Experimental data on perioperative chemotherapy (PeCT) indicate that its initiation might be most useful if administered as close as possible to…”
Get full text

Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients : A phase II study by NOLE, F, MUNZONE, E, GOLDHIRSCH, A, MANDALA, M, CATANIA, C, ORLANDO, L, ZAMPINO, M. G, MINCHELLA, I, COLLEONI, M, PERUZZOTTI, G, MARROCCO, E

“…Chemotherapy regimens for patients with advanced breast cancer or large primary tumours (including locally advanced disease) usually contain anthracyclines,…”
Get full text

P64 A randomized trial of axillary dissection versus no axillary dissection for patients with clinically node negative breast cancer and micrometastases in the sentinel node by Galimberti, V, Cecilio Sahium de Almeida, R, Rodriguez, J, Pagani, G, Sagona, A, Burgoa, L, Scarano, E, Peruzzotti, G, Colleoni, M, Goldhirsch, A

Get full text

Bone scan had no role in the staging of 765 consecutive operable T1–2N0–1 breast cancer patients without skeletal symptoms by Curigliano, G., Ferretti, G., Colleoni, M., Marrocco, E., Peruzzotti, G., Cicco, C. De, Paganelli, G., Goldhirsch, A.

Get full text

Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen by Orlando, L, Colleoni, M, Curigliano, G, Nolè, F, Ferretti, G, Masci, G, Peruzzotti, G, Minchella, I, Intra, M, Veronesi, P, Viale, G, Goldhirsch, A

“…Primary chemotherapy for locally advanced breast cancer, usually an anthracycline-containing regimen, improves local disease control allowing for an initially…”
Get more information

Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN) by Nolè, F., Minchella, I., Colleoni, M., Orvieto, E., Munzone, E., de Braud, F., Peruzzotti, G., Martinelli, G., Zampino, M. G., Catania, C., Pizzamiglio, M., Veronesi, P., Zurrida, S., Galimberti, V., Goldhirsch, A., Veronesi, U.

“…Background: Biological considerations support the use of primary chemotherapy in operable breast cancer; and despite wide variations of used regimens, clinical…”
Get full text

Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay by Curigliano, G., Colleoni, M., Renne, G., Mazzarol, G., Gennari, R., Peruzzotti, G., de Braud, F., Robertson, C., Maiorano, E., Veronesi, P., Nolè, F., Mandalà, M., Ferretti, G., Viale, G., Goldhirsch, A.

“…Background Male breast cancer (MBC) is an uncommon disease, and most of our current knowledge of its biology, natural history and treatment has been…”
Get full text

Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): Is prophylaxis required? by Orlando, L., Colleoni, M., Nolè, F., Biffi, R., Rocca, A., Curigliano, G., Ferretti, G., Peruzzotti, G., de Braud, F., Masci, G., Goldhirsch, A.

Get full text